Table 1.
Variables | Crohn’s disease | Ulcerative colitis | p-value |
---|---|---|---|
Diagnosis age | 43.80 ± 21.59 | 45.87 ± 20.83 | 0.0281 |
Gender (M% /F%) | 49.3 /50.7 | 57.7/42.3 | 0.0019 |
Smoking habit | 43.9 /56.1 | 35.2 / 64.8 | 0.0001 |
Immun. therapy | 38.4/61.6 | 26.4 / 73.6 | 0.0002 |
Duration of therapy | 12.27 ± 8.67 | 14.92 ± 9.84 | 0.0032 |
Biological drugs (BD) | 18.4/81.6 | 8.7/91.3 | 0.0004 |
Duration of BD | 12.23 ± 7.33 | 16.03 ± 9.41 | 0.0053 |
Re-hospitalization | 45.6 / 54.4 | 27.8 / 72.2 | 0.0008 |
Adverse events | 17.9 / 82.1 | 9.2 / 90.8 | 0.0007 |
Infections | 7.0/93.0 | 7.6 / 92.4 | 0.6274 |
Cancers | 3.6 / 96.4 | 2.5 / 97.5 | 0.2755 |
Diabetes | 5.6 / 94.4 | 10.6/89.4 | 0.0006 |
Hypertension | 20.3 / 79.7 | 19.6/80.4 | 0.7376 |
Heart failure | 5.7 / 94.3 | 5.7 / 94.3 | 0.9852 |
Kidney failure | 2.1 /97.9 | 2.6 / 97.4 | 0.5074 |
Pulmonary failure | 3.6/96.4 | 5.1 /94.9 | 0.1553 |
Neuropathy | 1.7/98.3 | 1.6/98.4 | 0.8858 |
Liver disease | 1.6/98.4 | 1.3 / 98.7 | 0.6075 |
Charlson score | 1.47 ± 1.81 | 1.20 ± 1.39 | 0.0316 |
Surgery | 19.7 /80.3 | 5.3 / 94.7 | 0.0003 |
Final exitus | 97.9/2.1 | 97.6 / 2.4 | 0.6643 |
Follow-up time | 34.57 ± 4.54 | 34.92 ± 4.16 | 0.0577 |
COMBINED p-value | 0.0000 |
Note: the values in italics identify the significant variables (level α = 0.05)